| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.24 | 0.0003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 0.0005 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0006 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |